Trending...
- Friendly Pro Services Helps Metro Detroit Homeowners Prepare for Changing Seasons, Power Outages and Winter Weather
- Radio Drive's New Album Walk With Me Delivers Two GRAMMY® Submissions Across Rock and Alternative Categories
- Las Vegas Attorney Thomas Boley Publishes Free Plain-English Guide to 100 Nevada Criminal Laws, in English and Spanish
FOR IMMEDIATE RELEASE
July 20, 2021
Contact: Kathleen Achtenberg, achtenbergk@michigan.org
Gov. Gretchen Whitmer announces Piramal Pharma Solutions expanding in SE Michigan, creating 31 high-wage jobs
LANSING, Mich. - Gov. Gretchen Whitmer joined the Michigan Economic Development Corporation today to announce that contract development and manufacturing organization (CDMO) Piramal Pharma Solutions (PPS) plans to expand in Riverview with support from the Michigan Strategic Fund, signaling continued economic recovery and the growth of the life sciences and healthcare industry in Michigan.
The project is expected to generate a total private investment of $35 million and create 31 high-wage jobs, resulting in a $200,000 Jobs Ready Michigan performance-based grant. Michigan was chosen for the project over another of the company's sites in Europe.
"Piramal Pharma Solutions' decision to expand in Southeast Michigan will create good-paying jobs for our talented workforce," said Governor Gretchen Whitmer. "Their expansion underscores the strength of Michigan's business climate and continued leadership in manufacturing across industry sectors. This is great news for workers and their families as we continue our economic jumpstart and put Michigan back to work. With the help of companies like PPS, we can put Michigan first and build back our state's economy stronger than ever before."
Piramal Pharma Solutions partners with and provides support to pharmaceutical companies as they seek FDA approval for new drug applications. The Riverview site, originally established as Ash Stevens in 1962, specializes in the development and manufacture of high-potency active pharmaceutical ingredients (HPAPIs), with an emphasis on oncology applications. It's a key site in the company's integrated offering, which combines services across a global network of sites to offer speed and simplicity to companies innovating new medicines for patients. Ash Stevens was acquired by Piramal Pharma Solutions in 2016, which has led to a significant increase in revenue and number of employees.
"The Riverview, Michigan site is an extremely important part of our global network, since it produces the active ingredients used in a number of developmental and commercial pharmaceutical treatments," said Piramal Pharma Solutions Chief Executive Officer Peter DeYoung. "This expansion enables us to better serve our current customers and meet additional market demand for drug substances, including HPAPIs, furthering our efforts to reduce the burden of disease on patients around the world."
In response to the increasing need for high potency APIs and the corresponding growth at the Riverview site, PPS plans to establish a new facility on an adjacent property that will house manufacturing, warehousing and laboratory operations. With the help of the Jobs Ready Michigan performance-based grant, PPS will be able to offer above-market salaries to attract and retain the talent it needs.
More on Michimich.com
"Michigan is grateful for Piramal Pharma Solutions' continued vote of confidence in our state and in our workforce. The message is clear: Michigan's economy is recovering, and we will continue to work building a championship economy here in the state," said Quentin Messer, Jr., CEO of the Michigan Economic Development Corporation and President and Chair of the Michigan Strategic Fund. "We appreciate the efforts of our local partners in Wayne County to support this project and will work with PPS over the coming months and years as it continues to grow and add jobs for Michigan residents."
The Jobs Ready Michigan Program is designed to provide grants for business expansion and location projects that lead to job creation and investments in Michigan that have a demonstrated training need, particularly in pursuing new opportunities for high-tech, high-demand, and high-wage jobs.
The project further strengthens Michigan's life sciences and healthcare industry and will bring high-wage, high-skill jobs to area residents, including positions such as chemists, quality assurance specialists, and R&D scientists.
"The growth of the Piramal Pharma Solutions site in Riverview is representative of Wayne County's versatility in expanding industries," said Wayne County Executive Warren Evans. "We look forward to supporting their expansion, which will bring 31 new jobs and a capital investment of up to $35 million to the city of Riverview and Wayne County."
For information on careers with Piramal Pharma Solutions, visit https://www.piramalpharmasolutions.com/careers.
About Michigan Economic Development Corporation (MEDC)
The Michigan Economic Development Corporation is the state's marketing arm and lead advocate for business development, job awareness and community development with the focus on growing Michigan's economy. For more information on the MEDC and our initiatives, visit www.MichiganBusiness.org. For Pure Michigan® tourism information, your trip begins at www.michigan.org. Join the conversation on: Facebook, Instagram, LinkedIn, and Twitter.
More on Michimich.com
About Piramal Pharma Solutions:
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug product. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovator and generic companies worldwide.
For more information please visit: www.piramalpharmasolutions.com | Twitter | LinkedIn
July 20, 2021
Contact: Kathleen Achtenberg, achtenbergk@michigan.org
Gov. Gretchen Whitmer announces Piramal Pharma Solutions expanding in SE Michigan, creating 31 high-wage jobs
- Full-service contract development and manufacturing organization will add 31 new jobs and invest $35 million in Riverview with support from the Michigan Strategic Fund
- Project solidifies company's presence in state, further strengthens Michigan's life sciences and healthcare industry
LANSING, Mich. - Gov. Gretchen Whitmer joined the Michigan Economic Development Corporation today to announce that contract development and manufacturing organization (CDMO) Piramal Pharma Solutions (PPS) plans to expand in Riverview with support from the Michigan Strategic Fund, signaling continued economic recovery and the growth of the life sciences and healthcare industry in Michigan.
The project is expected to generate a total private investment of $35 million and create 31 high-wage jobs, resulting in a $200,000 Jobs Ready Michigan performance-based grant. Michigan was chosen for the project over another of the company's sites in Europe.
"Piramal Pharma Solutions' decision to expand in Southeast Michigan will create good-paying jobs for our talented workforce," said Governor Gretchen Whitmer. "Their expansion underscores the strength of Michigan's business climate and continued leadership in manufacturing across industry sectors. This is great news for workers and their families as we continue our economic jumpstart and put Michigan back to work. With the help of companies like PPS, we can put Michigan first and build back our state's economy stronger than ever before."
Piramal Pharma Solutions partners with and provides support to pharmaceutical companies as they seek FDA approval for new drug applications. The Riverview site, originally established as Ash Stevens in 1962, specializes in the development and manufacture of high-potency active pharmaceutical ingredients (HPAPIs), with an emphasis on oncology applications. It's a key site in the company's integrated offering, which combines services across a global network of sites to offer speed and simplicity to companies innovating new medicines for patients. Ash Stevens was acquired by Piramal Pharma Solutions in 2016, which has led to a significant increase in revenue and number of employees.
"The Riverview, Michigan site is an extremely important part of our global network, since it produces the active ingredients used in a number of developmental and commercial pharmaceutical treatments," said Piramal Pharma Solutions Chief Executive Officer Peter DeYoung. "This expansion enables us to better serve our current customers and meet additional market demand for drug substances, including HPAPIs, furthering our efforts to reduce the burden of disease on patients around the world."
In response to the increasing need for high potency APIs and the corresponding growth at the Riverview site, PPS plans to establish a new facility on an adjacent property that will house manufacturing, warehousing and laboratory operations. With the help of the Jobs Ready Michigan performance-based grant, PPS will be able to offer above-market salaries to attract and retain the talent it needs.
More on Michimich.com
- Allstream Energy Partners, SEO Experts in Oil and Gas, Awarded Gas Processing OEM Agreement
- Growth Story Expands: $54.6M Contract, $30M Revenue Run Rate, 800+ Customers, 50+ Patents & New AI Cybersecurity Products for Cycurion, Inc $CYCU
- Sky Quarry Restarts Nevada's Only Crude Oil Refinery — A Major New Chapter Begins in This Highly Lucrative sector for N A S D A Q: SKYQ
- Nutriband Inc. (N A S D A Q: NTRB) Breaks Into Uncharted Territory: 52-Week High Eclipsed as Shares Surge 22% —AVERSA™ Puts Investors on High Alert
- Jacqui Condon Selected to Workers' Compensation Panels for Three Professional Athlete Associations
"Michigan is grateful for Piramal Pharma Solutions' continued vote of confidence in our state and in our workforce. The message is clear: Michigan's economy is recovering, and we will continue to work building a championship economy here in the state," said Quentin Messer, Jr., CEO of the Michigan Economic Development Corporation and President and Chair of the Michigan Strategic Fund. "We appreciate the efforts of our local partners in Wayne County to support this project and will work with PPS over the coming months and years as it continues to grow and add jobs for Michigan residents."
The Jobs Ready Michigan Program is designed to provide grants for business expansion and location projects that lead to job creation and investments in Michigan that have a demonstrated training need, particularly in pursuing new opportunities for high-tech, high-demand, and high-wage jobs.
The project further strengthens Michigan's life sciences and healthcare industry and will bring high-wage, high-skill jobs to area residents, including positions such as chemists, quality assurance specialists, and R&D scientists.
"The growth of the Piramal Pharma Solutions site in Riverview is representative of Wayne County's versatility in expanding industries," said Wayne County Executive Warren Evans. "We look forward to supporting their expansion, which will bring 31 new jobs and a capital investment of up to $35 million to the city of Riverview and Wayne County."
For information on careers with Piramal Pharma Solutions, visit https://www.piramalpharmasolutions.com/careers.
About Michigan Economic Development Corporation (MEDC)
The Michigan Economic Development Corporation is the state's marketing arm and lead advocate for business development, job awareness and community development with the focus on growing Michigan's economy. For more information on the MEDC and our initiatives, visit www.MichiganBusiness.org. For Pure Michigan® tourism information, your trip begins at www.michigan.org. Join the conversation on: Facebook, Instagram, LinkedIn, and Twitter.
More on Michimich.com
- New Metallized PE Film from Pregis Brings Recyclability to High-Barrier Food Packaging at Pack Expo International in Chicago
- Golden Limousine International Partner Trey McKenney
- Transformational $104 Million Musculoskeletal Healthcare Opportunity as Expansion Strategy Accelerates for Cardiff Lexington Corp (Stock Symbol: CDIX)
- PropAccount.com Launches Marketing Hub Within PropGenie, Giving Prop Firm Operators an Automated Marketing Team
- Save 15 Percent Off Florida Keys Accommodations with KeysCaribbean's Advance Purchase Rate Discount
About Piramal Pharma Solutions:
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug product. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovator and generic companies worldwide.
For more information please visit: www.piramalpharmasolutions.com | Twitter | LinkedIn
0 Comments
Latest on Michimich.com
- Radio Drive's New Album Walk With Me Delivers Two GRAMMY® Submissions Across Rock and Alternative Categories
- Kaplan Morrell and Attorney Jacqui Condon Selected to Represent Professional Women's Soccer Players in Workers' Compensation Matters
- ClearSight Therapeutics Receives NIH SBIR Phase I Award for Conjunctivitis and EKC Research
- Lunai Bioworks (N A S D A Q: LNAI) Takes Parkinson's Discovery to the Next Level With Exclusive Tanaist Agreement
- Revenue Optics Names Prat Patibandla Director of Growth Marketing
- CIMdata to Host Free Educational Webinar on Navigating PLM End-of-Life
- Independent Autopsies Are Changing Civil Cases: Kansas City Forensic Explains Why Families Are Seeking Second Opinions
- Harborside Senior Living Announces New Partnership With Huron Valley PACE
- JEGS Launches Transformed Digital Commerce Platform Powered by PhaseZero
- Subject matter experts: Present your ideas at IISE Annual Conference 2027 in Louisville
- Cummings Graduate Institute Celebrates New Doctor of Behavioral Health Graduates
- Visit London Appoints The SEO Works for AI-First Search Strategy
- Inglewood Associates and Gordon Brothers Provide Update on Sale Process for 925 Euclid Avenue in Cleveland
- Century Fasteners Corp. Exhibiting at the 2026 International Fastener Expo
- Las Vegas Attorney Thomas Boley Publishes Free Plain-English Guide to 100 Nevada Criminal Laws, in English and Spanish
- Bank Statement Loans Up to $30 Million: Lendmire Announces High-Net-Worth Financing
- Total Detail: Empty Your Vehicle Before Your Detailing Appointment for Best Results
- LaChance Brothers Excavating Encourages Homeowners to Prepare Septic Systems Before Winter Arrives
- NYC Big Book Award Celebrates 10th Anniversary with Announcement of 2026 Winners
- Regional Magazines Shine at IRMA Awards